Peanut Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Drug Class (Antihistamines, Epinephrine, Immunotherapies, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), By Region and Competition

Industry : Healthcare
Pages : NA
Published Date : NA

Customization Enquiry

Buy Now

Single User Licence

$4500

Multi-User Licence

$5500

Custom Research Licence

$8000

Summary

Request Sample

Report Description

Global Peanut Allergy Treatment Market is expected to see an impressive growth during the forecast period, 2024-2028. This growth is accounted for by the increasing awareness of peanut allergy, and advances in technology.

Peanut allergy is a serious and potentially life-threatening condition affecting millions of people worldwide. The Peanut Allergy Treatment Market has been growing rapidly in recent years due to the increasing prevalence of peanut allergy and the need for effective treatment options.

Advances in research have led to a better understanding of the mechanisms underlying peanut allergy, which has enabled the development of more targeted and effective treatments.

For example, the development of allergen-specific immunotherapy and gene therapies would not have been possible without advances in biotechnology and genetic engineering.

Many pharmaceutical companies and research institutions have recognized the potential of the peanut allergy treatment market and are investing heavily in developing new treatments through research and development.

Additionally, the regulatory environment is another factor driving the growth of peanut allergy treatments. Regulatory agencies such as the FDA and the European Medicines Agency (EMA) have recently issued guidelines aimed at improving the safety and efficacy of peanut allergy treatments. These guidelines have provided greater clarity for companies developing new treatments and have helped to drive innovation in the Peanut Allergy Treatment Market.

Immunotherapy, epinephrine auto-injectors, food labeling regulations, alternative foods, and gene therapy are trends that are shaping the future of peanut allergy treatment.

Immunotherapy is a treatment that aims to desensitize the patient's immune system to the allergen, in this case, peanuts. It involves introducing the allergen to the patient in gradually increasing doses over a period of several months or years, allowing the body to build up a tolerance to the allergen. Immunotherapy is a prominent form of treatment that reduced the severity of allergic reaction of peanuts.

Gene therapy is an effective treatment option that involves altering the genes responsible for producing the allergic response to peanuts. This therapy aims to eliminate the allergic response altogether, providing a potential cure for peanut allergies. While gene therapy is still in the experimental stage, it shows great promise for the future of peanut allergy treatment.

The growth of Global Peanut Allergy Treatment Market is hampered by various challenges These challenges include the risk of severe allergic reactions, limited access to treatment, the cost of treatment, limited effectiveness, and a lack of understanding about the condition.

The last three years have seen several significant product launches related to peanut allergy treatment, providing new options for those who suffer from this condition. These products are helping to transform the peanut allergy treatment market, providing patients with new options for managing their condition and improving their quality of life. In 2020, Aimmune Therapeutics launched Palforzia, the first FDA-approved treatment for peanut allergy. Palforzia is an oral immunotherapy drug that gradually desensitizes patients to peanuts, reducing their risk of having an allergic reaction. This treatment has the potential to be life-changing for those with peanut allergy, providing a new option for managing their condition.

In 2019, DBV Technologies launched Viaskin Peanut, a peanut allergy treatment that uses a patch to deliver small amounts of peanut allergen through the skin. The treatment is designed to gradually desensitize patients to peanuts and reduce the risk of allergic reactions. Viaskin Peanut has been shown to be effective in clinical trials and has received FDA fast track designation.

In 2019, Johnson & Johnson announced plans to launch a peanut allergy patch that delivers small amounts of peanut allergen through the skin. The patch is designed to gradually desensitize patients to peanuts and reduce the risk of allergic reactions. The peanut allergy patch is currently undergoing clinical trials and has the potential to be a game-changer in the peanut allergy treatment market.

ARA-101 is an oral immunotherapy drug developed by Aimmune Therapeutics that desensitizes patients to peanuts. ARA-101 is currently undergoing clinical trials and has shown promising results in reducing the risk of allergic reactions to peanuts. If approved, ARA-101 could be a valuable addition to the peanut allergy treatment market.

Increasing Awareness of Peanut Allergy

The increasing prevalence of peanut allergy is driving the growth of the Global Peanut Allergy Treatment Market. Peanut allergies have become a significant public health concern, affecting millions of people worldwide, and the number of cases continues to rise.

As a result, there is an increasing demand for effective treatments for peanut allergies. This has led to the development of various products and therapies that can help manage and treat peanut allergies, such as peanut allergy immunotherapy, oral immunotherapy, and sublingual immunotherapy.

The market includes various products such as peanut allergy vaccines, oral immunotherapy drugs, sublingual immunotherapy drugs, and others.

The market is being driven by increased investments in research and development activities by pharmaceutical companies and government organizations to develop effective treatments for peanut allergies. Additionally, the increasing awareness about peanut allergies among the general population is expected to boost the demand for peanut allergy treatments in the coming years.

Growing Awareness Regarding the Peanut Allergy

The growing understanding of peanut allergy is influencing the growth of the Global Peanut Allergy Treatment Market. With advances in medical research, there is a greater understanding of the causes and mechanisms of peanut allergy, which is leading to the development of new and more effective treatments.

For example, researchers are now exploring new approaches to immunotherapy that could provide longer-lasting protection against peanut allergies. Additionally, new diagnostic tools are being developed that can help physicians more accurately diagnose and manage peanut allergies.

As the understanding of peanut allergies continues to grow, it is likely to fuel demand for new and innovative treatments. This is particularly true as more people become aware of the serious health risks associated with peanut allergies and the impact they can have on quality of life.

Furthermore, the increasing awareness of peanut allergies has led to more funding being directed towards research and development of new treatments for peanut allergies. This, in turn, is driving the growth of the Global Peanut Allergy Treatment Market as companies are developing new products and therapies to meet the needs of patients.

The growing understanding of peanut allergies has a significant impact on the growth of the Global Peanut Allergy Treatment Market.

Increasing Investment in Research & Development

Increasing investment in research and development is a major driver of the growth of the Global Peanut Allergy Treatment Market. As the prevalence of peanut allergy continues to rise, there is a growing need for more effective treatments, which has led to increased investment in research and development activities.

Pharmaceutical companies, government organizations, and research institutions are investing heavily in developing new and innovative treatments for peanut allergy. For example, there is ongoing research into new types of immunotherapies, including oral and sublingual immunotherapy, as well as the development of new peanut allergy vaccines.

These investments are also driving the development of more accurate and efficient diagnostic tools for peanut allergies, which will help physicians to diagnose and manage the condition more effectively.

Moreover, the increasing investment in research and development activities has led to the discovery of new and innovative methods for peanut allergy treatment. This includes novel formulations of existing drugs, as well as new delivery mechanisms for these drugs.

Download Free Sample Report

Market Segmentation

Global Peanut Allergy Treatment Market can be segmented by drug class, route of administration, distribution channel, sand region. Based on drug class, the market can be divided into antihistamines, epinephrine, immunotherapies, and others. Based on route of administration, the market is divided into oral, intravenous, and others. Based on distribution channel, the market is divided into retail pharmacies, hospital pharmacies, and online pharmacies. Regionally, the Peanut Allergy Treatment Market can be categorized into North America, Europe, Asia Pacific, South America, and Middle East & Africa.

Market Players

Vedanta Biosciences, Inc., Alladapt Immunotherapeutics, Inc., Regeneron Pharmaceuticals Inc., Aravax Pty Ltd, Teva Pharmaceutical Industries Limited, Prota Therapeutics Pty Ltd., Aimmune Therapeutics, Inc. (Nestle), DBV Technologies SA, Sanofi SA are some of the leading players operating in the Global Peanut Allergy Treatment Market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
Report coverage	Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends
Segments covered	By Drug Class By Route of Administration By Distribution Channel
Regional scope	North America, Europe, Asia Pacific, South America, Middle East & Africa
Key companies profiled	Vedanta Biosciences, Inc., Alladapt Immunotherapeutics, Inc., Regeneron Pharmaceuticals Inc., Aravax Pty Ltd, Teva Pharmaceutical Industries Limited, Prota Therapeutics Pty Ltd., Aimmune Therapeutics, Inc. (Nestle), DBV Technologies SA, Sanofi SA
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, Global Peanut Allergy Treatment Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Global Peanut Allergy Treatment Market, By Drug Class:

o Antihistamines

o Epinephrine

o Immunotherapies

o Others

Global Peanut Allergy Treatment Market, By Route of Administration:

o Oral

o Intravenous

o Others

Global Peanut Allergy Treatment Market, By Distribution Channel:

o Retail Pharmacies

o Hospital Pharmacies

o Online Pharmacies

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Peanut Allergy Treatment Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Peanut Allergy Treatment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validations

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Peanut Allergy Treatment Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Drug Class (Antihistamines, Epinephrine, Immunotherapies, Others)

5.2.2. By Route of Administration (Oral, Intravenous, Others)

5.2.3. By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)

5.2.4. By Region

5.2.5. By Company (2022)

5.3. Product Map

5.3.1. By Drug Class

5.3.2. By Route of Administration

5.3.3. By Distribution Channel

5.3.4. By Region

6. North America Peanut Allergy Treatment Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Drug Class

6.2.2. By Route of Administration

6.2.3. By Distribution Channel

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Peanut Allergy Treatment Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Drug Class

6.3.1.2.2. By Route of Administration

6.3.1.2.3. By Distribution Channel

6.3.2. Canada Peanut Allergy Treatment Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Drug Class

6.3.2.2.2. By Route of Administration

6.3.2.2.3. By Distribution Channel

6.3.3. Mexico Peanut Allergy Treatment Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Drug Class

6.3.3.2.2. By Route of Administration

6.3.3.2.3. By Distribution Channel

7. Europe Peanut Allergy Treatment Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Drug Class

7.2.2. By Route of Administration

7.2.3. By Distribution Channel

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. France Peanut Allergy Treatment Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Drug Class

7.3.1.2.2. By Route of Administration

7.3.1.2.3. By Distribution Channel

7.3.2. Germany Peanut Allergy Treatment Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Drug Class

7.3.2.2.2. By Route of Administration

7.3.2.2.3. By Distribution Channel

7.3.3. United Kingdom Peanut Allergy Treatment Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Drug Class

7.3.3.2.2. By Route of Administration

7.3.3.2.3. By Distribution Channel

7.3.4. Italy Peanut Allergy Treatment Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Drug Class

7.3.4.2.2. By Route of Administration

7.3.4.2.3. By Distribution Channel

7.3.5. Spain Peanut Allergy Treatment Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Drug Class

7.3.5.2.2. By Route of Administration

7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Peanut Allergy Treatment Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Drug Class

8.2.2. By Route of Administration

8.2.3. By Distribution Channel

8.2.4. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Peanut Allergy Treatment Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Drug Class

8.3.1.2.2. By Route of Administration

8.3.1.2.3. By Distribution Channel

8.3.2. India Peanut Allergy Treatment Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Drug Class

8.3.2.2.2. By Route of Administration

8.3.2.2.3. By Distribution Channel

8.3.3. Japan Peanut Allergy Treatment Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Drug Class

8.3.3.2.2. By Route of Administration

8.3.3.2.3. By Distribution Channel

8.3.4. South Korea Peanut Allergy Treatment Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Drug Class

8.3.4.2.2. By Route of Administration

8.3.4.2.3. By Distribution Channel

8.3.5. Australia Peanut Allergy Treatment Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Drug Class

8.3.5.2.2. By Route of Administration

8.3.5.2.3. By Distribution Channel

9. South America Peanut Allergy Treatment Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Drug Class

9.2.2. By Route of Administration

9.2.3. By Distribution Channel

9.2.4. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Peanut Allergy Treatment Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Drug Class

9.3.1.2.2. By Route of Administration

9.3.1.2.3. By Distribution Channel

9.3.2. Argentina Peanut Allergy Treatment Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Drug Class

9.3.2.2.2. By Route of Administration

9.3.2.2.3. By Distribution Channel

9.3.3. Colombia Peanut Allergy Treatment Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Drug Class

9.3.3.2.2. By Route of Administration

9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Peanut Allergy Treatment Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Drug Class

10.2.2. By Route of Administration

10.2.3. By Distribution Channel

10.2.4. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Peanut Allergy Treatment Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Drug Class

10.3.1.2.2. By Route of Administration

10.3.1.2.3. By Distribution Channel

10.3.2. Saudi Arabia Peanut Allergy Treatment Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Drug Class

10.3.2.2.2. By Route of Administration

10.3.2.2.3. By Distribution Channel

10.3.3. UAE Peanut Allergy Treatment Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Drug Class

10.3.3.2.2. By Route of Administration

10.3.3.2.3. By Distribution Channel

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Global Peanut Allergy Treatment Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview

15.2. Product Offerings

15.3. Recent Developments

15.4. Key Personnel

15.5. SWOT Analysis

15.5.1. Vedanta Biosciences, Inc.

15.5.2. Alladapt Immunotherapeutics, Inc.

15.5.3. Regeneron Pharmaceuticals Inc.

15.5.4. Aravax Pty Ltd

15.5.5. Teva Pharmaceutical Industries Limited

15.5.6. Prota Therapeutics Pty Ltd.

15.5.7. Aimmune Therapeutics, Inc. (Nestle)

15.5.8. DBV Technologies SA

15.5.9. Sanofi SA

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Peanut Allergy Treatment Market?

The increasing awareness of peanut allergy, improved understanding of peanut allergy, advances in technology, increased investment in research and development, and the regulatory environment are some of the factors driving the growth of Global Peanut Allergy Treatment Market.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Peanut Allergy Treatment Market to be Dominated by Growing Investment in Research & Development Through 2028.

Jun, 2023

Increasing Prevalence of Peanut Allergy is expected to drive the growth of Global Peanut Allergy Treatment Market in the forecast period, 2024-2028.